Comparative Effectiveness of [18F]-Fluorocholine PET-CT and Pelvic MRI With Diffusion-Weighted Imaging for Staging in Patients With High-Risk Prostate Cancer

被引:57
|
作者
Pinaquy, Jean-Baptiste [1 ]
De Clermont-Galleran, Henri [1 ,2 ]
Pasticier, Gilles [3 ]
Rigou, Gerald [4 ]
Alberti, Nicolas [4 ]
Hindie, Elif [1 ,2 ]
Mokrane, Yacoub [5 ]
Fernandez, Philippe [1 ,2 ]
机构
[1] Hop Pellegrin, Dept Nucl Med, F-33076 Bordeaux, France
[2] Univ Bordeaux, INCIA, UMR CNRS 5287, Bordeaux, France
[3] Hop Pellegrin, Dept Urol, F-33076 Bordeaux, France
[4] Hop Pellegrin, Dept Radiol, F-33076 Bordeaux, France
[5] Hop Pellegrin, Dept Pathol, F-33076 Bordeaux, France
来源
PROSTATE | 2015年 / 75卷 / 03期
关键词
F-18]-fluorocholine; DWI; MRI; prostate cancer; staging; EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; LYMPH-NODES; RADICAL PROSTATECTOMY; LOCALIZATION; INTERMEDIATE; NOMOGRAM; DISEASE;
D O I
10.1002/pros.22921
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BACKGROUND. Accurate staging is important before surgical decision in patients with high-risk prostate cancer (PCa). The purpose of this study was to prospectively compare the diagnostic performance of F-18-FCholine and MRI with diffusion weighted imaging (DWIMRI) for local and regional lymph node (LN) staging before radical prostatectomy (RP) with extended pelvic lymphadenectomy (PLND). METHODS. We identified 47 patients who underwent F-18-FCholine and DWIMRI followed by surgical treatment (either prostatectomy or LN dissection or an association of prostatectomy and LN dissection) between May 2010 and December 2012 at Bordeaux University Hospital. These patients were part of a prospective study (EudraCT number 2009-014839-21) evaluating the interest of F-18-FCholine in staging of high-risk PCa. Diagnostic performances were retrospectively determined for each of F-18-FCholine and DWIMRI considering LN invasion, each of prostate sextants, capsular invasion and extension to seminal vesicles. F-18-FCholine and MR findings were correlated with histological findings. RESULTS. In a region-based LN analysis, the sensitivity and positive predictive value specificity were respectively, 56% and 98% for F-18-Choline, and 17% and 97% for DWIMRI. In a patient-based analysis the sensitivity and positive predictive value were respectively 78% and 94% for F-18-Choline and 33% and 84% for DWIMRI (P = 0.015). For tumor staging, DWIMRI showed better performances with a better specificity (69%) for sextants analysis and sensitivity to detect seminal vesicle invasion (73% vs. 36%). CONCLUSIONS. F-18-FCholine imaging appears to provide helpful additional information in the staging of high-risk PCa. It appears essential for predicting LN status due to its higher sensitivity and specificity for LN involvement. However, despite excellent performance, it cannot replace MRI that remains better for tumoral localization and local evaluation, especially for seminal vesicle invasion. PATIENT SUMMARY. This study highlights the interest of F-18-Choline in the staging of high risk prostate cancer in addition with DWI MRI, especially so in the evaluation of lymph node involvement due to its high sensitivity and excellent specificity. (C) 2014 Wiley Periodicals, Inc.
引用
收藏
页码:323 / 331
页数:9
相关论文
共 50 条
  • [41] Parametric Fusion Imaging Using 11C-Choline PET/CT And Diffusion-Weighted MRI for the Identification of High-Risk Primary Prostate Cancer
    Piert, M. R.
    Park, H.
    Khan, A.
    Hussain, H.
    Meyer, C.
    Shah, R.
    Wood, D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S343 - S343
  • [42] FDG PET/CT and Diffusion-Weighted MRI in Primary Staging of Rectal Cancer
    Arcay, A.
    Aydin, F.
    Keven, A.
    Kiprak, Z. G.
    Engin, M. N.
    Caglayan, C. N. Dundar
    Boz, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S526 - S527
  • [43] 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients
    Selnaes, Kirsten M.
    Kruger-Stokke, Brage
    Elschot, Mattijs
    Willoch, Frode
    Storkersen, Oystein
    Sandsmark, Elise
    Moestue, Siver A.
    Tessem, May-Britt
    Halvorsen, Dag
    Kjobli, Eirik
    Angelsen, Anders
    Langorgen, Sverre
    Bertilsson, Helena
    Bathen, Tone F.
    EUROPEAN RADIOLOGY, 2018, 28 (08) : 3151 - 3159
  • [44] 18F-Fluciclovine PET/MRI for preoperative lymph node staging in high-risk prostate cancer patients
    Kirsten M. Selnæs
    Brage Krüger-Stokke
    Mattijs Elschot
    Frode Willoch
    Øystein Størkersen
    Elise Sandsmark
    Siver A. Moestue
    May-Britt Tessem
    Dag Halvorsen
    Eirik Kjøbli
    Anders Angelsen
    Sverre Langørgen
    Helena Bertilsson
    Tone F. Bathen
    European Radiology, 2018, 28 : 3151 - 3159
  • [46] [18F]fluorocholine PET/CT in the assessment of bone metastases in prostate cancer -: Reply
    Cimitan, Marino
    Bortolus, Roberto
    Morassut, Sandro
    Canzonieri, Vincenzo
    Garbeglio, Antonio
    Baresic, Tanja
    Borsatti, Eugenio
    Drigo, Annalisa
    Trovo, Mauro G.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (08) : 1318 - 1319
  • [47] Impact of fluorocholine(18F) PET/CT in case of occult recurrence of prostate cancer
    Talbot, Jean-Noel
    Huchet, Virginie
    Rousseau, Caroline
    Cochet, Alexandre
    Olivier, Pierre
    Courbon, Frederic
    Foehrenbach, Herve
    Nataf, Valerie
    JOURNAL OF NUCLEAR MEDICINE, 2011, 52
  • [48] [18F]DCFPyL PET/CT for Imaging of Prostate Cancer
    Rowe, Steven P.
    Buck, Andreas
    Bundschuh, Ralph A.
    Lapa, Constantin
    Serfling, Sebastian E.
    Derlin, Thorsten
    Higuchi, Takahiro
    Gorin, Michael A.
    Pomper, Martin G.
    Werner, Rudolf A.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2022, 61 (03): : 240 - 246
  • [49] 18F FACBC PET/CT for nodal staging in high risk prostate cancer: preliminary accuracy data
    Zanoni, L.
    Bossert, I.
    Nanni, C.
    Pultrone, C.
    Schiavina, R.
    Giunchi, F.
    Fiorentino, M.
    Fonti, C.
    Matti, A.
    Ricciolino, S.
    Lodi, F.
    Porreca, A.
    Brunocilla, E.
    D'Errico, A.
    Fanti, S.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2016, 43 : S234 - S235
  • [50] Cost-effectiveness of response evaluation after chemoradiation in patients with advanced oropharyngeal cancer using 18F–FDG-PET-CT and/or diffusion-weighted MRI
    Marjolein JE Greuter
    Charlotte S Schouten
    Jonas A Castelijns
    Pim de Graaf
    Emile FI Comans
    Otto S Hoekstra
    Remco de Bree
    Veerle MH Coupé
    BMC Cancer, 17